investor compensation

Rosen Law Firm urges Masonite investors who sold stock between June 2023 and February 2024 to join securities lawsuit alleging material disclosure failures.

Rosen Law Firm filed securities class action against Enphase Energy ($ENPH) alleging false statements on inventory management and tax credit impacts. Lead plaintiff deadline April 20, 2026.

Rosen Law Firm files securities class action against $NAVN, alleging false IPO disclosures about sales expenses. Lead plaintiff deadline set for April 24, 2026.

Rosen Law Firm reminds Kyndryl investors of April 13, 2026 lead plaintiff deadline in securities fraud class action alleging false financial statements and control failures.

Rosen Law Firm filed securities class action against Franklin BSP Realty Trust ($FBRT) alleging false statements about business prospects and dividend sustainability. Investor deadline: April 27, 2026.

Beyond Meat faces securities class action over asset valuation disclosures spanning Feb-Nov 2025. Lead plaintiff deadline March 24, 2026.

BlackRock TCP Capital faces securities class action alleging investment valuation misstatements and NAV overstatement. Affected shareholders have until April 6, 2026, to pursue claims.

Rosen Law Firm investigates KDDI for alleged misleading disclosures. Stock fell 11.4% after earnings delay; shareholders may pursue class action compensation.

Rosen Law Firm files securities class action against Ardent Health for alleged misrepresentations in accounts receivable and insurance reserves. March 9 deadline for lead plaintiff claims.

Vistagen Therapeutics faces securities lawsuit over alleged fasedienol misstatements. Investors who purchased VTGN stock April 2024-December 2025 may be eligible for compensation; lead plaintiff deadline is March 16, 2026.

Plug Power faces securities class action alleging false DOE loan and hydrogen facility statements. Eligible investors have until April 3, 2026 to join.

Securities class action filed against $SMR alleging false statements about ENTRA1 Energy partnership. Investors who bought stock May-November 2025 may qualify for compensation.

REGENXBIO faces class action lawsuit over RGX-111 gene therapy trial disclosures. Lead plaintiff deadline is April 14, 2026.

Mereo BioPharma faces securities class action for allegedly concealing failed Phase 3 trials for setrusumab. Investors have until April 6, 2026 to act.

Rosen Law Firm sues Snowflake for allegedly hiding how new products would harm consumption and revenue. Lead plaintiff deadline: April 27, 2026.

uniQure faces securities class action over alleged misrepresentations regarding FDA approval status of Huntington's Disease trial design and regulatory timeline delays. Lead plaintiff deadline April 13, 2026.

Beyond Meat faces securities class action over alleged false disclosures about asset valuations and impairment charges. Lead plaintiff deadline: March 24, 2026.

SDM investors must join securities class action by March 16, 2026, alleging company misrepresented market manipulation and insider trading risks.

Rosen Law Firm sued Bath & Body Works for allegedly making false statements about business strategy and financial performance, misleading investors about adjacencies and brand collaborations.

Rosen Law Firm sues Franklin BSP Realty Trust for allegedly misleading investors about dividend sustainability. Lead plaintiff deadline set for April 27, 2026.